VitaNova Life Sciences (VNOV) Change in Accured Expenses (2019 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Change in Accured Expenses came in at $944.0 in Q3 2026, up 132.51% YoY from $406.0 in Q3 2025, and up 131.55% on a QoQ basis from -$2992.0 in Q2 2026.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Change in Accured Expenses (2019 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Change in Accured Expenses across 8 years of filings, most recently posting $944.0 for Q3 2026.
- Change in Accured Expenses for Q3 2026 came in at $944.0, up 132.51% year-over-year; the trailing twelve-month figure through Jul 2026 was $18612.0 (up 237.09% YoY), and the FY2026 annual result was $18074.0, up 341.57% from the prior year.
- Change in Accured Expenses for Q3 2026 stood at $944.0, up from -$2992.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $12418.0 in Q1 2026 and bottomed at -$13900.0 in Q4 2024.
- Average Change in Accured Expenses over 5 years is $1873.4, with a median of $1700.0 recorded in 2022.
- The widest annual swing landed in 2024, when Change in Accured Expenses slumped 1919.37%; it then soared 2256.04% in 2025.
- Year by year, Change in Accured Expenses stood at $2705.0 in 2022, then slumped by 71.76% to $764.0 in 2023, then sank by 1919.37% to -$13900.0 in 2024, then soared by 159.29% to $8242.0 in 2025, then plunged by 88.55% to $944.0 in 2026.
- The last three Change in Accured Expenses figures came in at $944.0 (Q3 2026), -$2992.0 (Q2 2026), and $12418.0 (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | -444.94 Mn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 83.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 53.59 Mn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 71.00 Mn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 70.88 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 92.87 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 6.07 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 127.97 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | -291.35 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 944.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -2,992.00 |
| Jan 31, 2026 | 12,418.00 |
| Oct 31, 2025 | 1,282.00 |
| Jul 31, 2025 | 7,366.00 |
| Apr 30, 2025 | -10,970.00 |
| Jan 31, 2025 | 10,888.00 |
| Oct 31, 2024 | -13,900.00 |
| Jul 31, 2024 | 6,500.00 |
| Apr 30, 2024 | 10,547.00 |
| Jan 31, 2024 | -505.00 |
| Oct 31, 2023 | 764.00 |
| Jul 31, 2023 | -1,900.00 |
| Apr 30, 2023 | 2,100.00 |
| Jan 31, 2023 | -3,600.00 |
| Oct 31, 2022 | 2,705.00 |
| Jul 31, 2022 | 4,647.00 |
| Apr 30, 2022 | 7,600.00 |
| Jan 31, 2022 | 1,700.00 |
| Oct 31, 2021 | 4,584.00 |
| Jul 31, 2021 | 3,544.00 |